.svg){kind=small}
Market Insights Snapshot
In May 2026, Decimal concentrated entirely in Capsules with a 100.0% category share, while category sales declined 51.10% year over year and 9.53% month over month; average price moved down 6.04% YoY to $36.22. Within the Capsules context in Ontario, Decimal held rank 7, indicating positioning below at least six rivals as overall brand sales trended down 51.10% YoY alongside a single-category exposure. The pattern implies that a full reliance on Capsules amplified the 9.53% MoM contraction into a sharper YoY slide, making rank 7 a function of both price deflation and concentration risk.
Given a 116.64% 24‑month sales lift juxtaposed with a 51.10% YoY decline, the shift suggests Decimal’s prior expansion phase is giving way to a consolidation cycle where a 100.0% Capsules mix and a 6.04% YoY price decrease trade margin for volume resilience. With rank 7 in Ontario and a 9.53% MoM dip concentrated in a single category, the brand’s positioning hinges on whether price-led tactics within Capsules can regain share faster than category headwinds erode it; the implication is that diversification or premium re-segmentation within Capsules would be required to offset the current 51.10% YoY pressure.
Competitive Landscape
Decimal sits at rank #7 in ON Capsules in May 2026, unchanged from #7 year over year, and also flat versus three months ago at #7, while the category’s top end shuffled with Glacial Gold rising from #4 to #2 and Tweed sliding from #2 to #5; at the same time, Aspire held #1 with a 20.6% YoY sales increase and Redecan stayed at #3 despite a 36.7% YoY sales decline. This combination—Decimal’s static #7 alongside upward mobility for Glacial Gold (+2 ranks, +39.1% YoY sales) and downward pressure on Tweed (-3 ranks, -47.4% YoY sales)—implies Decimal is neither capturing share from weakening incumbents nor being pulled up by category mix shifts, pointing to a stasis that risks entrenchment if conversion or distribution levers are not activated.
Notable Products
The steepest movement in May 2026 came from CBD:THC 1:1 Balance Softgels 30-Pack (150mg CBD, 150mg THC), which fell 30.4% while dropping to rank 3, and THC Capsules 90-Pack (900mg) declined 13.7% at rank 2, signaling pressure on mixed and high-dose formats. In contrast, CBD/THC 5:5 Balanced Softgels 90-Pack (450mg CBD, 450mg THC) surged 73.1% to rank 5 even as THC 10 Softgels 30-Pack (300mg) slipped 4.9% at rank 1, with four of the top ten concentrated in Capsules indicating category depth rather than breadth. The $27,888 in May 2026 sales for THC Capsules 90-Pack (900mg) coupled with its double-digit decline suggests volume is consolidating toward balanced formulations despite leadership erosion at the top. The pattern implies Decimal’s product mix is tilting toward mid-pack balanced softgels, indicating a shift from pure-THC dominance to formats that hedge potency with CBD.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
